Literature DB >> 11191358

Nitric oxide synthase in pulmonary hypertension: lessons from knockout mice.

K A Fagan1, I McMurtry, D M Rodman.   

Abstract

Nitric oxide (NO) is implicated in a wide variety of biological roles. NO is generated from three nitric oxide synthase (NOS) isoforms: neuronal (nNOS), inducible (iNOS), and endothelial (eNOS) all of which are found in the lung. While there are no isoform-specific inhibitors of NOS, the recent development and characterization of mice deficient in each of the NOS isoforms has allowed for more comprehensive study of the importance of NO in the lung circulation. Studies in the mouse have identified the role of NO from eNOS in modulating pulmonary vascular tone and in attenuating the development of chronic hypoxic pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191358

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  17 in total

Review 1.  Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.

Authors:  Stephen L Archer; E Kenneth Weir; Martin R Wilkins
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

2.  EXPRESS: Gremlin1 blocks vascular endothelial growth factor signalling in the pulmonary microvascular endothelium.

Authors:  Simon Coyle Rowan; Lucie Piouceau; Joanna Cornwell; Lili Li; Paul McLoughlin
Journal:  Pulm Circ       Date:  2018-10-04       Impact factor: 3.017

3.  Human primary lung endothelial cells in culture.

Authors:  Suzy A A Comhair; Weiling Xu; Lori Mavrakis; Micheala A Aldred; Kewal Asosingh; Serpil C Erzurum
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-15       Impact factor: 6.914

4.  Genotype-phenotype effects of Bmpr2 mutations on disease severity in mouse models of pulmonary hypertension.

Authors:  Andrea L Frump; Arunima Datta; Sampa Ghose; James West; Mark P de Caestecker
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

Review 5.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  Things We "kNOw" and Do Not "kNOw" about Pulmonary Hypertension.

Authors:  Jarrod W Barnes; Rakesh P Patel
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

Review 7.  Vascular Metabolic Mechanisms of Pulmonary Hypertension.

Authors:  Xiao-Fan Shi; Yun-Chao Su
Journal:  Curr Med Sci       Date:  2020-07-17

8.  Phosphodiesterase type 5 and high altitude pulmonary hypertension.

Authors:  A A Aldashev; B K Kojonazarov; T A Amatov; T M Sooronbaev; M M Mirrakhimov; N W Morrell; J Wharton; M R Wilkins
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

9.  Phosphorylation inactivation of endothelial nitric oxide synthesis in pulmonary arterial hypertension.

Authors:  Sudakshina Ghosh; Manveen Gupta; Weiling Xu; Deloris A Mavrakis; Allison J Janocha; Suzy A A Comhair; Mohammad Mahfuzul Haque; Dennis J Stuehr; Jun Yu; Peter Polgar; Sathyamangla V Naga Prasad; Serpil C Erzurum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-04-29       Impact factor: 5.464

10.  Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.

Authors:  Vincent G DeMarco; Javad Habibi; Adam T Whaley-Connell; Rebecca I Schneider; James R Sowers; Bradley T Andresen; Alex A Gutweiler; Lixin Ma; Megan S Johnson; Carlos M Ferrario; Kevin C Dellsperger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.